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ORIGINAL ARTICLE

Axonal Growth Arrests After an Increased Accumulation
of Schwann Cells Expressing Senescence Markers
and Stromal Cells in Acellular Nerve Allografts
Louis H. Poppler, MD,1 Xueping Ee, MD,1 Lauren Schellhardt, BA,1 Gwendolyn M. Hoben, MD, PhD,1
Deng Pan, BS,1 Daniel A. Hunter,1 Ying Yan, MD, PhD,1 Amy M. Moore, MD,1 Alison K. Snyder-Warwick, MD,1
Sheila A. Stewart, PhD,2 Susan E. Mackinnon, MD,1 and Matthew D. Wood, PhD1

Acellular nerve allografts (ANAs) and other nerve constructs do not reliably facilitate axonal regeneration
across long defects (>3 cm). Causes for this deficiency are poorly understood. In this study, we determined what
cells are present within ANAs before axonal growth arrest in nerve constructs and if these cells express markers
of cellular stress and senescence. Using the Thy1-GFP rat and serial imaging, we identified the time and location
of axonal growth arrest in long (6 cm) ANAs. Axonal growth halted within long ANAs by 4 weeks, while axons
successfully regenerated across short (3 cm) ANAs. Cellular populations and markers of senescence were
determined using immunohistochemistry, histology, and senescence-associated b-galactosidase staining. Both
short and long ANAs were robustly repopulated with Schwann cells (SCs) and stromal cells by 2 weeks.
Schwann cells (S100b+) represented the majority of cells repopulating both ANAs. Overall, both ANAs
demonstrated similar cellular populations with the exception of increased stromal cells (fibronectin+/S100b-/
CD68- cells) in long ANAs. Characterization of ANAs for markers of cellular senescence revealed that long
ANAs accumulated much greater levels of senescence markers and a greater percentage of Schwann cells
expressing the senescence marker p16 compared to short ANAs. To establish the impact of the long ANA
environment on axonal regeneration, short ANAs (2 cm) that would normally support axonal regeneration were
generated from long ANAs near the time of axonal growth arrest (‘‘stressed’’ ANAs). These stressed ANAs
contained mainly S100b+/p16+ cells and markedly reduced axonal regeneration. In additional experiments,
removal of the distal portion (4 cm) of long ANAs near the time of axonal growth arrest and replacement with
long isografts (4 cm) rescued axonal regeneration across the defect. Neuronal culture derived from nerve
following axonal growth arrest in long ANAs revealed no deficits in axonal extension. Overall, this evidence
demonstrates that long ANAs are repopulated with increased p16+ Schwann cells and stromal cells compared to
short ANAs, suggesting a role for these cells in poor axonal regeneration across nerve constructs.

Introduction

P

eripheral nerve injuries are common, affecting
5% of trauma emergency visits, and cause devastating
morbidity.1 Because nerve grafts are necessary to repair a
severed nerve in most cases,2 generating an off-the-shelf
nerve construct (i.e., nerve guidance conduit) that can be
used to repair a variety of clinical scenarios (short gap, long
gap, and small- and large-diameter nerves) has been a longstanding goal in peripheral nerve regeneration research.
Acellular nerve allografts (ANAs) are a promising nerve

construct because they retain native nerve tissue extracellular matrix proteins and structure facilitating axonal regeneration. In addition, ANAs and other nerve constructs
that contain an internal scaffold promote superior axonal
regeneration across gaps compared to ‘‘empty’’ tubes.3 However, studies using any off-the-shelf nerve construct show
that they have limited capacity for regeneration in long gap
injury models (>3 cm).4–6
Causes of limited regeneration in long nerve constructs
are poorly understood. However, recent work with long ANAs
implicates cellular senescence as one underlying mechanism
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of poor regenerative outcome. Our group demonstrated limited axonal regeneration across ANAs as length increased.
We observed the accumulation of cells expressing senescent
markers in long ANAs but were unable to establish a direct
causal relationship as it is unclear whether cells expressing
senescent markers were present before axonal growth arrest.5 In addition, the contribution of other cells was not
known, and the capacity of neurons to grow axons for the
extended period required to cross these long ANAs has not
been established.
Senescent cells arise in tissues with increasing age as well
as prematurely in pathological conditions, such as oxidative
stress, cellular overproliferation, and oncogenic signaling.7–13
Senescence is a state of irreversible arrest of cellular proliferation frequently accompanied by altered gene and protein expression, referred to as the senescence-associated
secretory phenotype (SASP).14–16 The SASP is replete with
chemokines, cytokines, growth factors, and extracellular remodeling enzymes that potentially change a regenerative
environment.7,15,17,18 While senescent cells play a role in
contributing to pathologies,15,16,18–22 they also have an essential role in tissue regeneration.23 Senescent cells, including fibroblasts, through components of their SASP,
mediate optimal wound healing in skin during injury.23
However, in a situation of inflammation-mediated premature senescence in fibroblasts, wound healing is impaired,
leading to increased scar formation.12 These results suggest
that cellular senescence has a multifaceted and contextdependent role in regeneration.
Axon regeneration depends on a complex combination
of changes in the milieu of growth factors, cell adhesion
molecules, and secreted molecules within injured nerve or
nerve constructs.24–29 Age-related changes to nerve, including decreased Schwann cell phagocytosis, macrophage recruitment, and growth factor expression, are associated with
poor regenerative outcome.30–32 Therefore, an accumulation
of senescent cells and/or changes in cell populations within
constructs could impact the regenerative process and the
number of axons that cross constructs, such as ANAs.
Our previous studies identified increased numbers of cells
expressing senescence markers in long ANAs after 10 weeks.
Therefore, it remains unclear if senescent cells play an active
role during axonal regeneration. Our current studies demonstrate the temporal relationship between cell populations,
senescence markers, and axonal regeneration. We hypothesized that cells expressing senescence-associated markers
precede axonal growth arrest in long ANAs and that the
ANA environment is causal to axonal arrest. These studies (1) identify the temporal and spatial pattern of axonal
growth in ANAs, (2) determine the cellular populations
repopulating ANAs and phenotypic state preceding axonal
growth arrest, and (3) demonstrate that ANAs contain an
environment that causes poor axonal regeneration.
Materials and Methods

All materials were obtained from Sigma-Aldrich unless
otherwise specified.
Animals and animal care

Adult male and female Thy1-GFP Sprague Dawley transgenic rats (200–250 g; 6–10 weeks old)33 and adult male
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Lewis rats (200–250 g; 7–9 weeks old; Charles River Laboratories) were randomized to groups and underwent sciatic
nerve transection and repair. At the appropriate endpoint,
the animals were sacrificed for assessment of nerve regeneration within the grafts, including characterization of
cellular populations, density, and functional phenotype.
Thy1-GFP animals have axons that express green fluorescence protein to provide optical imaging capabilities to
track the axonal progression after injury. Lewis (RT-11
MHC) and Sprague Dawley (RT-1b MHC) rat strains are
known to be MHC incompatible for use as allograft donors.
Surgical procedures and perioperative care were performed in accordance with the Institutional Animal Studies
Committee and the National Institutes of Health guidelines.
Animals were fed a PicoLab Rodent Diet 20 (Purina Mills
Nutrition International) and water ad libitum. Animals were
housed in a central animal care facility and monitored daily
for signs of infection or distress by trained veterinary staff.
Experimental design

Animals underwent sciatic nerve transection and grafting
with a long 6-cm or short 3-cm ANA or transection without
repair. A cohort of Thy1-GFP rats with long or short ANAs
underwent serial in vivo imaging at 2, 4, 6, and 10 weeks to
measure axonal extension. In all other Thy1-GFP rats, imaging at the time of tissue harvest (2 or 4 weeks) and animal
sacrifice was used to indicate the furthest point of axonal
regeneration and marked with a 6-0 silk suture (Ethicon).
The proximal 3 cm of ANAs was divided into three even
(*10 mm) segments for analysis: proximal, axonal front, and
distal. These segments were analyzed for cellular populations.
A set of Lewis rats assessed the impact of the local ANA
environment during axonal growth arrest (4 weeks). Axon
regeneration was measured following repair of a sciatic
nerve gap with standard short ANAs (2 cm) or short ‘‘stressed’’ ANAs. To generate ‘‘stressed’’ ANAs, genetically
identical Lewis rats underwent sciatic transection and repair
with a 6-cm ANA and were allowed to regenerate until 4
weeks. At this time, these Lewis rats were sacrificed, and a
2-cm segment of the distal portion of their long ANA was
excised and used to repair new sciatic transection injuries in
a second group of Lewis rats (not previously injured). The
presence of cells with senescent markers in these ANAs was
confirmed with senescence-associated b-galactosidase (SAbgal) activity (details below) at the time of harvest. Axon
regeneration was quantified using nerve histomorphometry,
and the quantity of cell populations and senescent markers
was quantified using immunohistochemistry 6 weeks after
short ANA grafting.3–5,34,35 Lewis rats that received fresh
(standard) 2-cm ANAs served as a positive control.
A final set of animals assessed the impact of axonal growth
arrest on neurons with two experiments. In the first experiment, Thy1-GFP rats with long ANAs were allowed to regenerate until 4 weeks. At this time, ANA distal to the point of
axonal growth arrest (*4 cm) was excised and replaced with a
fresh isograft (*4 cm). The ability of axons to resume regeneration was measured 6 weeks later using in vivo imaging
and quantified for GFP+ intensity. Controls for these experiments were 6-cm ANAs with sham exposure at 4 weeks but no
rescue. In the second experiment, the ability of neurons to
extend axons or neurites was assessed. Dorsal root ganglia
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(DRG) were harvested from animals with long ANAs at 4
weeks and dissociated for neurons (culture methods follow).
These ‘‘arrested neurons’’ were cultured with or without primary normal Schwann cells to measure neurite extension and
compared to DRG taken from uninjured nerve (‘‘uninjured
neurons’’) under similar conditions.
Surgical procedures

Surgeries were done using aseptic technique and an
operating microscope ( JEDMED/KAPS). Anesthesia was
performed using a cocktail of ketamine (75 mg/kg; Fort
Dodge Animal Health) and dexmedetomidine (0.5 mg/kg;
Pfizer Animal Health). Donor nerves for ANA processing
were harvested as described previously,4 and animals were
then euthanized (below). For experimental animals, the right
sciatic nerve was exposed and transected 5 mm proximal to
the distal trifurcation, sparing the sural nerve. The appropriate graft was sutured into the nerve gap with 9-0 nylon
microsuture (Sharpoint). A two-layer closure of muscle and
skin was performed using 4-0 vicryl and 5-0 nylon suture,
respectively (Ethicon). At the appropriate endpoints, animals were anesthetized as before, and ANAs and nerve were
excised and collected. In addition, lumbar regions L4 and L5
DRG were also collected from a set of Thy1-GFP Sprague
Dawley rats. Following sample collection, rats were euthanized with injection of Somnasol (150 mg/kg; Delmarva
Laboratories).
ANA processing

ANAs were decellularized using a series of detergents
by methods described by Hudson et al.36,37 In brief, the
nerves were repeatedly washed in deionized water and three
detergents in a sodium phosphate buffer: Triton X-100,
sulfobetaine-16 (SB-16), and sulfobetaine-10 (SB-10). Triton X-100 was used in place of Triton X-200 (a discontinued
product line; Dow Chemicals) as Triton X-100 at a similar
concentration has been determined to effectively remove
cells and proteins and reduce immunogenicity within nerve
allografts.36,38 All grafts were washed and stored in 10 mM
phosphate-buffered 50 mM sodium solution at 4C and used
within 3 days.
In vivo imaging

Nerve grafts in Thy1-GFP rats were imaged intraoperatively immediately following graft implantation and at 2, 4,
6, and/or 10 weeks using methods described previously.33
In brief, sciatic nerve was exposed and imaged using a
fluorescence-enabled dissecting microscope (Olympus MVX10;
Olympus America, Inc.) under GFP (488 nm) fluorescent
and bright-field filters. The images were recorded monochromatically using MetaMorph version 7.1.0.0. (Universal
Imaging Corporation). Images were standardized according
to magnification (6.3 ·), exposure time (100–300 ms), and
orientation. All images were standardized with respect to
brightness and contrast. Distance from the proximal suture
line to the distant-most point of green fluorescence and the
distal suture line was measured using MetaMorph. In addition, axonal extension was normalized to graft length to
account for changes in graft size over time, which is inherent to the regenerative process.39
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Histology, histomorphometry, and electron microscopy

Histology and histomorphometric analysis were performed on long and short ANAs as well as in unrepaired,
distal injured nerve as previously described.40 Briefly, tissue
was harvested and stored in 3% glutaraldehyde (Polysciences, Inc.), then postfixed in 1% osmium tetroxide, and
serially dehydrated in ethanol and toluene. These tissues
were embedded in epoxy (Polysciences) and sectioned on an
ultramicrotome for *1-mm cross sections. Slides were then
counterstained with 1% toluidine blue dye and analyzed at
1000· on a Leitz Laborlux S microscope. Myelinated axon
counts were quantified on a Leco IA32 Image Analysis
System (Leco) by an observer blinded to the experimental
groups.
Samples from short and long ANAs and distal unrepaired
nerve harvested at 4 weeks were randomly selected for
quantification of cellular populations with electron microscopy. Specimens were preserved as above and embedded in
Araldite 502 resin. They were then cut into 90-nm cross
sections at each 5-mm interval along the length of the graft
using an LKB III microtome. Sections were stained with
uranyl acetate and lead citrate. Within the area of axonal
regeneration, ultramicrographs at 1500–2000· magnification
were taken using a Joel 1200EX electron microscope. Cellular populations were identified by a trained histologist
blinded to the experimental group from which samples were
taken. Various cell types were counted per high-power field
using a minimum of 10 fields per sample. Cells represented
and counted included Schwann cells, stromal cells, which
included fibroblasts, perineurial cells, pericytes, and mast
cells, and leukocytes. Endothelial cells were insufficiently
represented to base comparisons between groups but counted
to determine the total cell number. The total number of cells
per field were normalized to the field area (density) to standardize counts for appropriate comparisons between groups.
Immunohistochemistry

Immunohistochemical (IHC) staining was used to identify
cell populations and cellular state (senescence) within the
area of axonal regeneration. ANAs were harvested and divided as described in the experimental design, including
normal nerve and distal injured nerve as control. All tissues
were explanted and immediately placed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 8–12 h and
then moved to 30% sucrose in PBS solution for 24–48 h.
Samples were then frozen in OCT Compound (VWR) and
cut as longitudinal 20-mm-thick sections onto pretreated
charged glass slides. Sections were rehydrated with PBS and
blocked using 2% normal goat serum and 0.5% bovine serum albumin before primary antibody staining. Primary
antibody in blocking buffer (above) was applied and incubated at 4C overnight with antibodies outlined in Table 1.
Sections were then washed in PBS and stained for the appropriate fluorochrome-conjugated secondary antibodies for
1 h at room temperature. All sections were mounted with
Fluoroshield mounting medium with DAPI (Abcam) and
then imaged using the NanoZoomer HT (Hamamatsu) at
overall 200· magnification or a Fluoview FV1000 confocal
microscope and acquisition system (Olympus) at overall
600· magnification (60· oil immersion objective). A minimum of three sections were analyzed and averaged for each
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Table 1. Immunohistochemistry Markers Used to Identify Cellular Populations and Senescence
Protein
marker

Target/function

S100b

Schwann cells

CD90
Fibronectin

Fibroblasts, endothelial cells,
T cells, and NK cells
Endoneurial cells (stromal cells)

CD68

Macrophages

p16

Cell cycle regulator

p53

Cell cycle regulator

Ki67

Cellular proliferation marker

Primary antibody
Polyclonal Rabbit Anti-S100b
(Dako)
Monoclonal Mouse Anti-CD90/
Thy1 (Abcam)
Polyclonal Goat Anti-Fibronectin
(Santa Cruz Biotechnology)
Monoclonal Mouse Anti-CD68
[ED1] (Abcam)
Monoclonal Mouse Anti-CDKN2A/
p16INK4a (Abcam)
Monoclonal Mouse Anti-p53
(Abcam)
Polyclonal Rabbit Anti-Ki67 (EMD
Millipore)

tissue area using ImageJ (NIH). For intensity analysis,
normal nerve was always included for sample staining as a
control and for normalization of staining intensity. For cell
counts, field size was kept standard at a 60· objective (600·
magnification overall), and colocalization of the primary
marker(s) with DAPI was considered a positive cell.
Histochemical analysis of senescence (SA-bgal)

SA-bgal staining was performed on ANAs immediately
following harvest. Samples were flash frozen in OCT
Compound (VWR) on liquid nitrogen and sectioned as
longitudinal 20-mm-thick slices collected on glass slides. All
areas within the epineurium of the nerve/ANA were assessed for SA-bgal activity. The Senescence Detection Kit
(Abcam) was used according to the manufacturer’s protocol.
Control nerve (normal uninjured nerve) was always included during staining. Sections were imaged at 20· magnification using the NanoZoomer HT. To compare staining
between groups, the average staining intensity was measured from normal nerve using ImageJ (NIH). Senescent
cells and the area they occupied were defined positive if SAbgal activity was at least two standard deviations greater
than the average staining intensity for normal uninjured
nerve. The total area of positive staining was normalized to
the total area of the ANA and reported as a percentage of the
tissue area positive for SA-bgal activity.
Neurite extension assay

DRG harvested from animals following axonal arrest
within long ANAs were dissociated to obtain neurons. These
neurons were compared to those without injury or axonal
arrest. To obtain neurons from DRG, DRG following excision were digested and minced in 0.125% collagenase
(195 U/mg; Worthington) and 0.05% dispase (Worthington)
at 37C for 75 min. Following enzyme solution removal, the
DRG were further digested in 0.05% trypsin (Gibco) at 37C
for 20 min. A 70-mm strainer (VWR) was used to strain the
cell solution, followed by cell resuspension in Dulbecco’s
modified Eagle’s growth medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum, 100 U/mL
penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL am-

Catalog
number

Dilution
factor

Z0311

1:500

AB225

1:1000

SC-6952

1:100

AB31630

1:100

AB54210

1:250

AB26

1:250

AB9260

1:300

photericin B. Cells were then plated at 2000 cells per well
either alone or on top of existing SC cultures (below) and
allowed to extend neurites for 48 h. Five wells per group
were prepared. Finally, 10–20 neurons per well were randomly selected and photographed at 10· under an FITC
(488 nm) filter (Omega Optical) on an Olympus IX81 microscope using Micro-Manager v1.4.41 The longest neurite
extension from the cell body and the number of branching
points were measured using ImageJ.42
To obtain SCs, the uninjured sciatic nerve of Lewis rats
was incubated in DMEM (Invitrogen) supplemented with
10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.25 mg/mL amphotericin B,
20 mg/mL bovine pituitary extract (Biomedical Tech, Inc.),
and 5 mM forskolin for 7 days.43–45 These nerves were then
placed in growth medium with 1.25 U/mL dispase (Worthington) and 0.5% collagenase IV (Worthington) at 37C
for 8–12 h. Next, digested nerves were strained and centrifuged at 400 g for 6 min to collect the cell component. Cells
were then cultured on poly-l-lysine (pLL)-coated tissue
culture dishes (BD Falcon) for 6 days. At this time, fibroblasts were complement killed with anti-Thy 1.1 antibody
(1:40 dilution in media; Serotec) and rabbit complement
(1:4 dilution in media). All cultures were performed at 37C
in a water-jacketed incubator at 5% CO2 and 20% O2. SCs
were seeded on pLL-coated 24-well plates (Corning) at a
density of 40,000 cells per well (100% confluency) and allowed to adhere for 24 h before neuronal plating. SC status
(i.e., lack of senescence markers) was confirmed in this
primary culture.
Statistical analyses

IBM SPSS version 22 was used for all statistical analyses. All data were compiled as mean – standard deviation.
Data were tested for normality graphically and using the
Kolmogorov–Smirnov test. ANOVA was used to test differences between groups with the primary comparison of
interest specified a priori and post hoc comparisons with
Tukey’s test. When two groups were compared, a t-test was
performed. A significance level of p < 0.05 was used in all
statistical tests performed.
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Results
Axonal regeneration arrests by 4 weeks in long (6 cm)
ANAs, while axons cross short (3 cm) ANAs

To identify the time of axonal growth arrest, we used
the Thy1-GFP rat to serially track axonal regeneration in
short (3 cm) and long (6 cm) ANAs over a 10-week period
with live optical imaging (Fig. 1A–D). Axons advanced
6.5 – 1.8 mm in the long ANAs for *4 weeks. However,
after 4 weeks, axonal extension was unchanged for the remaining 6 weeks (‘‘arrested’’). In contrast, axons regenerated
approximately the same distance within short ANAs by 4
weeks and continued to regenerate after 4 weeks, where axons reached the distal nerve by 10 weeks achieving successful
regeneration across the short ANA (Fig. 1E). As constructs
contracted as time progressed39 for both ANAs, axonal extension measurements were also normalized to the ANA
length (Fig. 1F). This analysis revealed the same conclusions.
In addition, both analyses revealed that axons failed to advance even 3 cm within a long ANA. As axonal growth arrested in long ANAs by 4 weeks, differential analyses
between these grafts to short ANAs at 4 weeks could identify
potentially causal factors involved in axonal growth arrest.
Peripheral nerve support cells repopulate
short and long ANAs

Normally, Schwann cells, stromal cells, such as fibroblasts,
and macrophages comprise the majority of cells in normal and
injured nerve.46–49 While Schwann cells and macrophages have
specific cellular markers, nerve stromal cells, such as fibroblasts, perineurial cells, pericytes, and mast cells, are typically
identified through exclusion from other cells (S100-/CD68-)
and association with fibronectin and/or collagen.48,50,51 Differential assessment of these cellular populations within the
ANAs (within the epineurial shealth) was performed by comparing the short ANAs (3 cm) to the proximal 3 cm of long
ANAs at 4 weeks as long ANAs still contain axons within this
portion of the ANA. Before graft excision, the area of the
axonal front was indicated using live imaging, and ANAs were
divided into three even (*10 mm) segments for analysis:
proximal, axonal front, and distal (Fig. 2A).
IHC staining for protein markers expressed by neural support cells was used to first screen spatial segments. S100b
(Schwann cell; Fig. 2B), CD90 (fibroblasts, endothelial cells, T
cells, and NK cells; Fig. 2C), and CD68 (macrophage; Fig. 2D)
mean intensities were generally similar between short and long
ANAs. A notable exception was CD90 mean intensity, which
was increased twofold to injured nerve by both short and long
ANAs, suggesting an increased presence of stromal cells, such
as fibroblasts, in either ANA (Fig. 2C). In addition, long ANAs
demonstrated *1.4-fold greater CD68 intensity compared to
short ANAs in their distal segment, suggesting differential
repopulation of macrophages (Fig. 2D). Overall, the IHC mean
intensity screen demonstrated that ANAs were repopulated by
the major support cells of nerve.
Based on the screen, the total cell density and individual cell
populations were quantified. As the total cell density did not
differ between long or short ANAs (Fig. 3A), we considered the
percentage of Schwann cells (S100b+), stromal cells (fibronectin+/S100b-/CD68-), and macrophages (CD68+). Schwann
cells represented the majority in either long or short ANAs.

FIG. 1. Axonal regeneration within ANAs. Thy1-GFP rats
were used to measure axonal growth through ANAs (red line
start of ANA; dashed line outlines ANA) over the time course
of 10 weeks, where the axonal front was used to measure the
distance axons extended (yellow bar). (A–D) Representative
images of optical macroscopic imaging of GFP axons regenerating through long 6-cm ANAs. (E, F) Axon growth into
6-cm ANAs is delayed relative to 3-cm ANAs (2 weeks), and
the axonal front does not change after 4 weeks (axonal growth
arrest). Axons continue to advance in 3-cm ANAs without
arresting their growth. Means with standard deviation are represented, n = 4 per group; * represents statistical significance
between 6-cm versus 3-cm ANAs, and # indicates statistical
significance between ANAs at different times ( p < 0.05).
Dotted lines represent either the end (black) or halfway (gray)
point of ANAs. ANAs, acellular nerve allografts. Color images
available online at www.liebertpub.com/tea
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FIG. 2. Assessment of cellular population marker intensity within ANAs. (A) The area of the axonal front was indicated
using live imaging in Thy1-GFP rats at 4 weeks, and ANAs were divided into three approximately even (10 mm) segments for
analysis: proximal, axonal front, and distal. Unrepaired, transected, distal nerve and normal uninjured nerve served as controls.
(B–D) Mean intensity for expressed proteins revealed the presence of Schwann cells (S100b), stromal cells (CD90), and
macrophages (CD68). CD90 was elevated relative to injured and normal nerve for either ANA length. Means with standard
deviation are represented, n = 4 per group; pink and gray dashed lines and shading are mean and standard deviation for normal
and injured nerve, respectively. # Indicates statistical significance between either ANA versus injured nerve ( p < 0.05). Color
images available online at www.liebertpub.com/tea
While the percentage of Schwann cells did not vary between
long or short ANAs (Fig. 3B), the percentage of stromal cells
was increased in long ANAs (Fig. 3C). The percentage of
macrophages did not differ within the axonal front or distal
segments (Fig. 3D) despite differences in the previous intensity
analysis. As stromal cells increased in both the axonal front and
distal segment of long ANAs, these data suggest that these cells
may play a role in axonal regeneration and growth in ANAs.
To further elucidate IHC characterization of cell populations, differential histological analysis of the axonal front
segment at 4 weeks was also performed. We relied on morphological characteristics as opposed to protein markers,
which may change based on cell phenotype (Fig. 4A). Again,
Schwann cells represented the majority of cells within ANAs

FIG. 3. Assessment of cellular
populations within ANAs using
immunohistochemical staining.
Spatial areas within ANAs
(Fig. 2A) were assessed for cell
populations. The total cell density
(A) between either ANA did not
differ. The composition of the total
cell population is represented for
the percentage of Schwann cells
(S100b; B), stromal cells (fibronectin+/S100b-/CD68-; C), and
macrophages (CD68; D). Means
with standard deviation are represented and n = 4 per group.
* Indicates statistical significance
between 6-cm versus 3-cm
ANAs ( p < 0.05). Color images
available online at www
.liebertpub.com/tea

and did not differ between long and short ANAs (Fig. 4B). In
this analysis, the percentage of stromal cells, such as fibroblasts, represented the second most represented cell in either
ANA and did not differ between long and short ANAs. These
data taken together with the IHC characterization of cell
populations suggest that Schwann cells and stromal cells
(particularly ones associated with fibronectin) likely play
roles in ANAs due their predominant presence.
Cellular senescence markers have accumulated
during axonal growth arrest in long ANAs

To understand why axon regeneration arrests in long but
not short ANAs, we considered phenotypic changes to the
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FIG. 4. Assessment of cellular populations within ANAs
using histology. The area of the axonal front (Fig. 2A) was
assessed using histology to identify cellular composition
within ANAs. (A) Representative electron micrograph of histological section of 3-cm ANA, where A, myelinated axons;
SC, Schwann cell; S, stromal cell; Lk, leukocyte; E, endothelial
cell (which were not quantified due to insignificant representation in electron microscopy images). (B) The composition of
the total cell population is represented for the percentage of
Schwann cells, stromal cells, and leukocytes. Means with
standard deviation are represented, n = 4 per group, and # indicates statistical significance to injured nerve ( p < 0.05).
Color images available online at www.liebertpub.com/tea
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cells repopulating the constructs. Senescent cells can be
characterized by increased SA-bgal52–55 and increased expression of cell cycle regulators (p16 and/or p53).14,15 At the
time of axon regeneration arrest, the percent area of ANAs
positive for SA-bgal activity was greater in long ANAs than
in short ANAs in all spatial segments (Fig. 5A, B), suggesting a greater accumulation of senescent cells. We also
screened these tissue segments using IHC mean intensity for
cell cycle regulators and proliferation markers. Mean intensity of cellular proliferation marker Ki67 (Fig. 5C) or cell
cycle regulator p53 (Fig. 5D) was not different between
ANAs. However, p16 was elevated in both long and short
ANAs compared to normal and injured nerve (Fig. 5E),
suggesting cells may be undergoing arrest through the p16
pathway (as opposed to the p53 pathway).
Based on the IHC screen, the percentage of Schwann cells
(S100b+) and stromal cells (fibronectin+) expressing p16
(colocalization) was quantified. While we previously did not
find differences in the percentage of Schwann cells between
either ANA (Fig. 3B), the percentage of Schwann cells
colocalized with p16 was increased in long compared to
short ANAs (Fig. 6A). Conversely, the percentage of stromal cells colocalized with p16 did not differ between either
ANA (Fig. 6B). Overall, the data demonstrate that long
ANAs accumulate greater levels of senescent markers with a
prominent increase in the ratio of Schwann cells colocalized
with p16, suggesting an increase in Schwann cells undergoing stress and/or senescence.
The cellular composition of long ANAs before axonal
growth arrest reflects similar trends to the composition
near the time of axonal growth arrest

To establish the presence of increased levels of prematurely
senescent and/or stromal cells before axonal arrest, long ANAs

FIG. 5. Assessment of cellular senescence markers within ANAs. (A) Representative images of SA-bgal (blue/dark staining)
activity taken from longitudinal sections of 3-cm (top) and 6-cm (bottom) ANAs at 4 weeks. Red line indicates proximal suture
line, and green line indicates end of 3-cm ANA or proximal half (3 cm) of 6-cm ANA. Spatial areas within ANAs (Fig. 2A)
were assessed for senescence markers. (B) Positive SA-bgal activity was measured as a percentage of the tissue area in 3- and
6-cm ANAs. Mean intensity of cell proliferation (Ki67; C) and cell cycle regulators (p53; D, p16; E) demonstrates elevated
p16 relative to normal and injured nerve. Means with standard deviation are represented, n = 4 per group; pink and gray dashed
lines and shading are mean and standard deviation for normal and injured nerve, respectively. * Indicates statistical significance between 6-cm versus 3-cm ANAs, and # indicates statistical significance between either ANA versus injured nerve
( p < 0.05). SA-bgal, senescence-associated b-galactosidase. Color images available online at www.liebertpub.com/tea
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at 4 weeks were compared to those at a 2-week endpoint. At 2
weeks, long ANAs had similar percentages of Schwann cells
and macrophages, but there was a substantial increase in the
percentage of stromal cells (fibronectin+/S100b-/CD68-)
(Fig. 7A–C). SA-bgal activity was similarly elevated at 2 and 4
weeks compared to injured nerve (Fig. 7D). Proportions of
Schwann cells (Fig. 7E) and stromal cells (Fig. 7F) expressing
p16 were similar at 2 and 4 weeks. Overall, the data suggest
that increased stromal cells and p16+ Schwann cells play a role
in axonal growth arrest in ANAs.
The long ANA environment at 4 weeks limits
axonal regeneration

FIG. 6. Assessment of cell populations expressing senescence markers within ANAs. Spatial areas within ANAs
(Fig. 2A) were assessed for cell populations colocalized
with senescence markers. The percentage of Schwann cells
(S100b+ cells) colocalized with p16 (A) is increased in long
compared to short ANAs, while that of stromal cells (fibronectin+ cells) colocalized with p16 (B) is not different for
either ANA. Normal nerve contained less than 5% p16+
cells (data not shown). Means with standard deviation are
represented, n = 4 per group, and * indicates statistical significance between 6-cm versus 3-cm ANAs ( p < 0.05).
Color images available online at www.liebertpub.com/tea

The impact of long ANAs on axonal regeneration was
further elucidated by generating short ANAs (2 cm; ‘‘stressed’’) taken from long ANAs (6 cm) 4 weeks following
their initial implantation (Fig. 8A). Using short constructs
(<3 cm), axonal regeneration across stressed ANAs is anticipated if the ANA environment is not a major factor.
While generating these stressed ANAs, SA-bgal activity
was confirmed, where results mirrored previous findings
(data not shown). At 6 weeks following retransplantation,
the ‘‘stressed’’ ANAs were assessed for cellular compositions
and compared to normal short ANAs (2 cm; ‘‘standard’’).
Both stressed and standard ANAs contained similar total
cell densities (Fig. 8B) as well as a similar percentage of
Schwann cells (Fig. 8C), which represented the majority of
cells. The percentage of Schwann cells expressing p16
(S100+/p16+) was increased in stressed ANAs compared to
standard ANAs (Fig. 8D), while there were no differences in
the percentage of stromal cells (fibronectin+) in either ANA
(data not shown). Comparing axonal regeneration across
these ANAs, axons regenerated across standard ANAs in all
animals by 6 weeks, where quantitative histological

FIG. 7. Assessment of cellular populations and senescence markers within long ANAs at 2 and 4 weeks. Spatial areas within
long ANAs were assessed at 2 and 4 weeks (Fig. 2A). The percentage of stromal cells (fibronectin+/S100b-/CD68-) was
substantially increased at 2 weeks compared to 4 weeks (B), while Schwann cells (S100b; A) and macrophages (CD68; C) had few
differences. (D) SA-bgal+ activity area is greater than injured nerve at 2 weeks, where unrepaired, transected, distal nerve and
normal uninjured nerve served as controls. The percentage of Schwann cells colocalized with p16 (E) is elevated at 2 weeks, while
that of fibroblasts colocalized with p16 (F) is not different from 4-week patterns. Means with standard deviation are represented
and n = 4 per group. * Indicates statistical significance between 6-cm versus 3-cm ANAs, and # indicates statistical significance
between either ANA versus injured nerve ( p < 0.05). Color images available online at www.liebertpub.com/tea
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FIG. 8. Assessment of the regenerative potential of long ANAs following axonal growth arrest. (A) Diagram depicting
how short ANAs (stressed) were derived from long ANAs 4 weeks following initial long ANA implantation. At a 6-week
endpoint, nerve grafts and distal nerve were assessed for regeneration and cell populations. Groups had similar cell densities
(B) and percentages of Schwann cells (S100b; C), but an increased percentage of S100b+/p16+ cells in stressed ANAs
compared to standard ANAs (D). (E) Histomorphometric analysis of myelinated axon counts between standard and stressed
ANAs. Histological micrographs of nerve cross sections distal to the grafts [stressed (F) and standard (G) ANA groups].
Representative myelinated axons are indicated with red arrows. Means with standard deviation are represented, n = 3 per
group, and * represents statistical significance ( p < 0.05). Color images available online at www.liebertpub.com/tea
measures demonstrated robust myelinated axon counts
(Fig. 8E, G). Conversely, no axons regenerated across
‘‘stressed’’ ANAs in any animal (Fig. 8F). Therefore, the
data demonstrate that the long ANA environment is deleterious to axonal regeneration.
Replacement of the long ANA region distal
to arrested axons ‘‘rescues’’ axonal
regeneration across the long gap

The impact of removing the deleterious ANA environment on axon regeneration was evaluated by two sets of
experiments. In the first, a fresh isograft (*4 cm) was used
to replace the distal end of the long ANA near the area of
axonal growth at 4 weeks (Fig. 9A). Previously, we determined that 4-cm isografts contain significantly less stromal
cells and senescent markers compared to 4-cm ANAs.5 All
animals receiving this isograft ‘‘rescue’’ regenerated axons
across the 4-cm isograft to cross the entire 6-cm gap. Without
removal and replacement of the ANA distal to axons, axonal
regeneration did not proceed. In the second experiment, DRG
were harvested from nerve receiving long ANAs at 4 weeks
and dissociated for neurons (‘‘arrested neurons’’). These
‘‘arrested neurons’’ were cultured to measure neurite extension and compared to DRG taken from uninjured nerve

(‘‘uninjured neurons’’). With or without normal cultured
Schwann cells to encourage neurite extension, ‘‘arrested
neurons’’ extended longer neurites than uninjured neurons
(Fig. 9B). The data suggest that components within long
ANAs cause axonal growth arrest as neurons are capable of
regenerating and extending axons after growth arrest.
Discussion

The current experiments demonstrate that prematurely
senescent cells are present before and during axonal growth
arrest in ANAs, which were placed in young rats where
senescent cells are not normally present.21 These studies
suggest that an increased accumulation of stromal cells
(fibronectin+/S100b-/CD68-) and senescent Schwann cells
within long ANAs impacts axonal regeneration across ANAs.
We also further demonstrate that axonal extension and regeneration are dependent on the environment within ANAs
as short ‘‘stressed’’ ANAs derived from long ANAs do not
promote axonal regeneration.
The initial microenvironment of any acellular tissue
construct, including ANAs, differs from denervated distal
nerve or auto/isografts in key ways, most notably cells.56,57
A variety of techniques have been used to generate acellular constructs, including repeated freeze–thaw cycles,
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FIG. 9. Assessment of the regenerative potential of neurons following axonal growth arrest. Long ANAs were replaced with
long isografts (‘‘rescue’’) at the area of axonal growth arrest at 4 weeks (diagram; A). (B) Representative images of nerve taken
from a Thy1-GFP rat demonstrate axonal extension (green) into the long isograft (rescue) or without rescue (n = 4 per group). Red
arrow indicates the proximal portion containing the original 6-cm ANA, and yellow arrow indicates the point of axonal front
before isograft placement. Analysis of GFP intensity between rescue and no-rescue groups revealed increased GFP intensity in
rescue spatial regions. (C) Neurons derived from nerve receiving long ANAs were harvested from DRG at 4 weeks after axonal
growth arrest. ‘‘Arrested neurons’’ were cultured with or without Schwann cells: Micrographs of neurite extension from these
neurons with yellow arrows indicating representative neurons. Neurite extension length was significantly greater for arrested
neurons compared to naive/uninjured nerve-derived neurons (n > 50 per group). Means with standard deviation are represented, and
* represents statistical significance ( p < 0.05). DRG, dorsal root ganglia. Color images available online at www.liebertpub.com/tea
exposure to radiation, lyophilization, extended storage in
cryopreservation solution, and currently employed detergent processing.4,6,37,57–61 While the failure of axons to
cross long nerve constructs is a well-established issue,
previous efforts using freeze-dried grafts reported difficultly with Schwann cell repopulation (S100+) and migration within long grafts.6,58,62–65 Therefore, failure of
axonal regeneration was more likely an issue of insufficient
support cells to allow axonal advancement. Our findings
demonstrate that detergent-processed ANAs regardless of
length are robustly repopulated with support cells, including

Schwann cells and stromal cells, such as fibroblasts, within
weeks of implantation.
We found an increase in stromal cells (fibronectin+/
S100b-/CD68-) in long compared to short ANAs, suggesting a possible cause for regenerative differences between
these ANA lengths. As histological assessment of stromal
cell numbers did not demonstrate differences in long and
short ANAs, these results suggest that a particular subpopulation of stromal cell is accumulating in long ANAs, such
as activated fibroblasts, which are associated with fibronectin.51,66 Therefore, further study to elucidate the role of
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stromal cell subpopulations will be needed. An additional
explanation for poor axonal regeneration is suggested by our
other major finding: Schwann cells expressing p16 (a senescence marker). Poor regenerative outcomes are associated with age-related changes to nerve, including decreased
Schwann cell phagocytosis, macrophage recruitment, and
growth factor expression.30–32 Therefore, the premature onset of
cellular senescence within a range of cells repopulating nerve
constructs could have an impact on regenerative outcomes.
Our results strongly suggest that Schwann cells exhibiting
markers of stress and/or senescence impact axonal regeneration as all analyses identified this cell associated with
poor regenerative outcomes.
Markers of cellular senescence were shown to be significantly elevated in long ANAs at the area of axonal growth
arrest both before and just before axonal growth arrest. This
result was in stark contrast to short ANAs. Short ANAs
contained significantly reduced numbers of cells expressing
senescent markers and facilitated axons across the construct.
The association of cells expressing senescence markers in
both short and long ANAs implies that the ratio of these
cells likely has an impact on regenerative outcome. Our
results demonstrate that long ANAs have higher levels of
senescence markers as well as an increased percentage of
Schwann cells expressing senescence markers (of the total
Schwann cell number) compared to short ANAs. This relationship suggests that the ratio of Schwann cells expressing markers of senescence (p16) is directly related to
axonal growth. In addition, as a much greater accumulation
of senescence markers and cells developed in long versus
short ANAs, this result strongly suggests that graft length is
a dependent variable affecting accumulation of cells expressing stress and senescence markers.
To confirm that the ANA environment was causal to axonal growth arrest, we directly assessed the ability of neurons
near the time of axonal arrest to extend neurites. Neurons
regenerated axons for an extended period (6 weeks) after
replacement of the local environment with isografts. In
addition, neurons harvested near the time of axonal growth
arrest also extended longer neurites than naive neurons.
While the neurons likely extended longer neurites than naive neurons due to injury ‘‘conditioning,’’67,68 these results
indicate that neurons are capable of growing across a long
distance (such as a long construct) if provided a permissive
growth environment. However, the status of neurons, including their gene profile and expression of senescence
markers, was not performed in the present work, limiting
our full knowledge of their axonal regenerative capabilities.
Overall, these studies establish a relationship where increased stromal cells (fibronectin+/S100b-/CD68-) and the
ratio of p16+ Schwann cells (S100b+) precede axonal growth
arrest in long ANAs. As such, these studies suggest that
these cells may play a role in the development of the deleterious environment within long ANAs. Future studies will
directly assess the role of subpopulations of stromal cells
and Schwann cells expressing senescent markers on axonal
regeneration to establish a causal relationship.
Conclusions

This study demonstrates that axonal growth arrest occurs
in long ANAs 4–6 weeks after repair, which is associated
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with repopulation of the graft with neural support cells and
an accumulation of cellular senescence markers before arrest. We also show that expression of senescence-associated
markers is significantly elevated in long ANAs relative to
short ANAs, where axonal regeneration is successfully facilitated across the graft. In addition, the percentage of
stromal cells (fibronectin+/S100b-/CD68-) and p16+ Schwann
cells (S100b+) is increased in long ANAs compared to short
ANAs. Finally, this study demonstrates that the long ANA
environment (as opposed to the longer distance axons must
grow) is a primary cause of the poor regenerative outcome.
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